In the evolving field of synthetic compounds, the p21 peptide sequence has garnered significant attention from those interested in neuro-regener p21 - Cyclin-dependent kinase inhibitor 1 ative research. As someone who has spent considerable time exploring the landscape of experimental research compounds, I find the structural nuances of this molecule particularly fascinating. When we look at P21 peptide information, it is essential to distinguish between the various iterations, such as the P021 variant and th Sequence. Sequence status. Complete. See also. sequence in UniParc or sequence clusters in UniRef. Length. 164. Mass (Da). 18,137. Last updated. 2021-04-07 v1.Read more e classic P21 peptide.
Structural Breakdown and Sequence
The core of the p21 peptide is often identified by its specific amino acid arrangement. A common sequence cited in literature is Ac-DGGLAG-NH2. This tetra-peptide is derived from the biologically active region of the human ciliary neurotrophic factor (CNTF). Interestingly, some formulations, often referred to as P21 peptide acetate, incorporate adamantane building blocks—specifically, the sequence DGGL-adamantane-G—to enhance stability and permeability.
This small sequence derived from the larger APP molecule is a synthetic peptide known for its regenerative and neuroprotective potential. Unlike the endogenous p21 (CIP1/WAF1) protein, which functions as a cyclin-dependent kinase inhibitor to regulate the cell cycle, the synthetic P21 compound is designed to mimic neurotrophic signaling pathways.
Distinguishing Entities in Research
It is crucial not to confuse the synthetic peptide with the p21 protein encoded by the *CDKN1A* gene. While the latter is a tumor-suppressing protein that helps control cell division and ensures that a cell "knows" when to bind to CDK to stop the cell cycle, the synthetic P21 is a targeted research tool.
Furthermore, historical studies on the RAS-p21 169–188 peptide focus on different mec 12 Jun 2025—P21 Peptide information, including chemical properties, structure, melting point, boiling point, density, formula, molecular weight, uses, hanisms, such as blocking oncogenic protein-induced cell activity. In contrast, the P21 peptide typically focused on in cognitive research is a distinct entity P21 - an overview | ScienceDirect Topics aimed at supporting neuronal health.
Personal Observations on Formulation
When reviewing P21 peptide uses for cancer, anti-aging, and wound healing, it is clear that the molecule's efficacy is linked to i p21 is a prognostic marker for renal cell carcinoma - PubMed - NIH ts structural integrity. The peptide's ability to cross the blood-brain barrier is often discussed in the context of its adamantylated structure.
In my experience reviewing various research materials, the P21 peptide dosage is a frequent topic of inquiry. However, researchers must always prioritize source verification and purity. The P21 peptide is 'Peptidealignment' shows detected peptides mapping to proteinsequence. The color ofpeptidebars reflects the number of PSM, and varies red to gray (red Read more a synthetic peptide that requires careful handling to ensure its stability. Whether you are looking at the p21-IRS chimeric peptide or the standard neurotrophic sequence, the molecular weight (often cited around 578.3 g/mol for the basic form) is a standard parameter for confirming the identity of the substance.
Summary of Key Entit p21 - Cyclin-dependent kinase inhibitor 1 ies
* Sequence: Ac-DGGLAG-NH2 or DGGL-adamantane-G.
* Classification: Synthetic neurotrophic peptide derivative.
* Mechanism: Modulates cellular pathways related to neurogenesis and survival.
* LSI/Variations: P021, Peptide 6c, CNTF-derived peptide, ADAM-P21.
As you delve deeper into the P21 peptide, remember that this field is purely experimental. The p21 appears to have a small membrane binding domain at the C-terminus in its natural protein state, a feature that highlights the complexity of nomenclature in this domain. Always rely on peer-reviewed data and reputable laboratory standards when analyzing these compounds. By keeping these distinctions clear, you can better navigate the complex world of peptide research without conflating endogenous proteins with synthetic research analogs.